CO7220324A2 - Polipeptidos relacionados con toxina con actividad microbiana y antiviral - Google Patents

Polipeptidos relacionados con toxina con actividad microbiana y antiviral

Info

Publication number
CO7220324A2
CO7220324A2 CO04124128A CO04124128A CO7220324A2 CO 7220324 A2 CO7220324 A2 CO 7220324A2 CO 04124128 A CO04124128 A CO 04124128A CO 04124128 A CO04124128 A CO 04124128A CO 7220324 A2 CO7220324 A2 CO 7220324A2
Authority
CO
Colombia
Prior art keywords
antiviral activity
toxin
microbial
related polypeptides
microbicidal
Prior art date
Application number
CO04124128A
Other languages
English (en)
Inventor
Luclanno Polonelli
Antonio Cassone
Paolo Neri
Luisa Bracci
Original Assignee
Univ Siena
Luciano Polonelli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Siena, Luciano Polonelli filed Critical Univ Siena
Publication of CO7220324A2 publication Critical patent/CO7220324A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

Todos los documentos citados aquí se incorporan como referencia en su totalidad.Esta invención se encuentra en el campo de los microbiocidas y antivirales, en particular aquellos derivados de las toxinas destructoras de levadura.
CO04124128A 2002-05-10 2004-12-10 Polipeptidos relacionados con toxina con actividad microbiana y antiviral CO7220324A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0210783.7A GB0210783D0 (en) 2002-05-10 2002-05-10 Anti-microbial polypeptides

Publications (1)

Publication Number Publication Date
CO7220324A2 true CO7220324A2 (es) 2015-03-20

Family

ID=9936462

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04124128A CO7220324A2 (es) 2002-05-10 2004-12-10 Polipeptidos relacionados con toxina con actividad microbiana y antiviral

Country Status (12)

Country Link
US (1) US7722876B2 (es)
EP (1) EP1504036B1 (es)
JP (1) JP4405912B2 (es)
AT (1) ATE514716T1 (es)
AU (1) AU2003233108A1 (es)
BR (1) BR0309921A (es)
CA (1) CA2484704A1 (es)
CO (1) CO7220324A2 (es)
DK (1) DK1504036T3 (es)
GB (1) GB0210783D0 (es)
NZ (1) NZ536957A (es)
WO (1) WO2003095493A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006093071A1 (ja) * 2005-02-28 2006-09-08 Genecare Research Institute Co., Ltd. βグルカン合成酵素を有する真菌に対して抗真菌活性を有する抗イディオタイプ抗体、およびその利用
EA201190025A1 (ru) 2008-11-25 2012-12-28 Байоджен Айдек Ма Инк. ПРИМЕНЕНИЕ АНТАГОНИСТОВ DR6 И p75 ДЛЯ ПРОМОТИРОВАНИЯ ВЫЖИВАНИЯ КЛЕТОК НЕРВНОЙ СИСТЕМЫ
WO2011060393A1 (en) * 2009-11-16 2011-05-19 Rasna Therapeutics Antimicrobial, antiviral, anticancer and immunomodulatory peptides and uses therefore
ES2634098T3 (es) 2011-01-14 2017-09-26 The Regents Of The University Of California Anticuerpos terapéuticos contra la proteína ROR-1 y procedimientos para el uso de los mismos.
PE20142243A1 (es) 2011-07-11 2015-01-11 Glenmark Pharmaceuticals Sa Anticuerpos que se unen a ox40 y sus usos
WO2020257625A1 (en) * 2019-06-21 2020-12-24 Rowley Paul A Compositions and methods for inhibiting yeast infections
US20220111018A1 (en) * 2020-06-19 2022-04-14 University Of Idaho Compositions and methods for inhibiting yeast infections
CN111848740B (zh) * 2020-08-04 2023-03-24 南京市妇幼保健院 一种阴道分泌源性多肽及其在抑制白色念珠菌感染中的应用
EP4147716A1 (en) * 2021-09-10 2023-03-15 Samatva Research Corporation Anti-virus moiety immobilised in a matrix

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5830470A (en) * 1992-09-07 1998-11-03 Kyowa Hakko Kogyo Co., Ltd. Humanized antibodies to ganglioside GM2
WO1998008090A1 (en) 1995-06-06 1998-02-26 Epigen, Inc. Anti-idiotypic antibodies to an epiglycanin
WO1997010354A1 (en) * 1995-09-11 1997-03-20 Kyowa Hakko Kogyo Co., Ltd. ANTIBODY AGAINTS α-CHAIN OF HUMAN INTERLEUKIN 5 RECEPTOR
PL329871A1 (en) * 1996-05-04 1999-04-12 Zeneca Ltd Monoclonal antibody agains cea, coniugates incorporating that antibody and their therapeutic application in the adept system
DK1069185T3 (da) * 1998-04-03 2011-06-27 Chugai Pharmaceutical Co Ltd Humaniseret antistof mod human vævsfaktor (TF) og fremgangsmåde til at konstruere humaniseret antistof
DE59913716D1 (de) * 1998-10-29 2006-09-07 Dakocytomation Denmark As Nachweis von säure-resistenten mikroorganismen im stuhl
EP1159300A2 (en) * 1999-02-12 2001-12-05 Genetics Institute, Inc. Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
DE60040466D1 (de) 1999-06-17 2008-11-20 Kyowa Hakko Kogyo Kk Diagnostikum und heilmittel für krankheiten unter teilnahme von makrozyten/makrophagen
US7740841B1 (en) 2000-01-28 2010-06-22 Sunnybrook Health Science Center Therapeutic method for reducing angiogenesis
EP1130032A1 (en) * 2000-02-28 2001-09-05 Gesellschaft für biotechnologische Forschung mbH (GBF) Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/KDR)
DE10019967A1 (de) 2000-04-20 2001-10-25 Fenning Biomed Gmbh Dr Antikörper gegen natives gp96, deren Herstellung und Verwendung
DK1292680T3 (da) * 2000-06-22 2010-03-08 Genentech Inc Agonist-anti-TrkC monoklonale antistoffer

Also Published As

Publication number Publication date
EP1504036A2 (en) 2005-02-09
NZ536957A (en) 2006-07-28
US20060280750A1 (en) 2006-12-14
WO2003095493A3 (en) 2004-06-03
BR0309921A (pt) 2005-02-09
GB0210783D0 (en) 2002-06-19
CA2484704A1 (en) 2003-11-20
JP2006506959A (ja) 2006-03-02
WO2003095493A2 (en) 2003-11-20
EP1504036B1 (en) 2011-06-29
AU2003233108A1 (en) 2003-11-11
JP4405912B2 (ja) 2010-01-27
ATE514716T1 (de) 2011-07-15
US7722876B2 (en) 2010-05-25
DK1504036T3 (da) 2011-10-24

Similar Documents

Publication Publication Date Title
EA200100447A1 (ru) Гибридные белки на основе бета-интерферона и их применение
ATE399177T1 (de) Derivate therapeutischer peptide
ATE368053T1 (de) Antimikrobielle peptide
WO2002010195A3 (en) Modified peptides with increased potency
DK0719340T3 (da) Klonet glutaminsyre-decarboxylase
AU8812498A (en) Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
DE69613137D1 (de) Zyklische peptidanaloga von somatostatin
CO7220324A2 (es) Polipeptidos relacionados con toxina con actividad microbiana y antiviral
ES2172044T3 (es) Supresion de la proliferacion de celulas t usando fragmentos peptidicos de proteina basica de mielina.
GB9606040D0 (en) Active peptide
BR0312889A (pt) Polipeptìdeo t20 peguilado
EP1006126A3 (en) Osteogenic peptides
DE68917837D1 (de) Peptid-Verbindungen.
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
DK1012175T3 (da) Peptid med affinitet til koagulationsfaktor VIII
DE69938130D1 (de) Neue peptide
ATE245168T1 (de) Peptide, die anti-zellanhaftungsaktivität aufweisen
NZ515332A (en) Lawsonia derived gene and related SodC polypeptides, peptides and proteins and their uses
AU2003264535A1 (en) Tumor antigen protein and utilization thereof
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
SE9700301D0 (sv) New compound
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof
ATE393777T1 (de) Tachykininpeptide, ihre präpeptide und sie kodierende gene
AU4956901A (en) Novel human 7tm proteins and polynucleotides encoding the same
BRPI0216042B8 (pt) polipeptídeo capaz de se ligar a ang-2, vetor de expressão, célula hospedeira, composição farmacêutica, e, uso dos referidos polipeptídeos.